PubMed:21740819 / 1127-1361
Annnotations
PubMed_Structured_Abstracts
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 0-234 | CONCLUSIONS | denotes | This new modified antisense oligonucleotides targeting VEGF-A can decrease VEGF-A expression and inhibit cell migration in SKOV3 ovarian cancer cells. This new oligonucleotides may be a promising therapeutic agent for ovarian cancers. |
CoMAGC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 75-81 | Gene | denotes | VEGF-A |
| E1 | 82-92 | Gene_expression | denotes | expression |
| E2 | 66-74 | Negative_regulation | denotes | decrease |
| T2 | 129-143 | ovarian cancer | denotes | ovarian cancer |
| T3 | 123-128 | ovarian cancer | denotes | SKOV3 |
| R1 | T1 | E1 | themeOf | VEGF-A,expression |
| R2 | E1 | E2 | themeOf | expression,decrease |
| R3 | T1 | T2 | CGE-decreased | VEGF-A,ovarian cancer |
| R4 | T1 | T2 | CCS-cancerTOnormal | VEGF-A,ovarian cancer |
| R5 | T1 | T2 | PT-observation | VEGF-A,ovarian cancer |
| R3 | T1 | T2 | IGE-unidentifiable | VEGF-A,ovarian cancer |